Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Elevated PSA levels can signal both malignant and benign prostate cancer But what does it mean if the PSA levels rise after a ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared an update on the side effects of her cancer treatments, less ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...

The Bishop of Manchester has revealed he has been diagnosed with prostate cancer. The Right Reverend David Walker said the ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many urologists remain unaware of their full potential to streamline practice ...

and personalized treatment strategies across multiple cancer types. The multimodal ArteraAI Prostate Test (AI Test) is currently the only test that provides insights for active surveillance as ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...